EUVIMEDEUVIMED entdecken
Open Access

Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?

Hala M Elsadek, Radwa O M Kamel, Marwa Abdallah Elsaid, Rasha Muhammad Rashed, Mona S Ali

Dermatology Practical & Conceptual · 30.10.2024 · 14 (4) · e2024226

DOI: 10.5826/dpc.1404a226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.10.2024. Verfasst von Hala M Elsadek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Psoriasis is a chronic inflammatory disease affecting 2%-3% of the global population via immune-mediated mechanisms. Osteopontin plays a crucial role in T-helper 1 and T-helper 17-mediated illnesses, including psoriasis. Ocular complications in psoriasis have been reported and their assessment is of importance. Osteopontin is normally expressed constitutively in ocular structures and is linked to ocular homeostasis.

Objective

This study aimed to clarify the role of osteopontin (OPN) in psoriasis (PS) and its correlation with disease severity and ocular manifestations.

Methods

A case-control study involving 40 psoriatic patients and an equal number of age and sex-matched healthy subjects was conducted. We used the psoriasis area severity index (PASI) to assess disease severity and performed a comprehensive ophthalmological examination. Additionally, we measured serum osteopontin levels using Enzyme-Linked Immunosorbent Assay (ELISA) in both groups.

Results

A significant elevation in serum OPN levels in psoriatic patients compared to controls was found (P=0.00). Furthermore, there was a highly significant positive correlation between serum OPN levels and patient age, disease duration, and PASI scores. Notably, a higher prevalence of ocular complications, including blepharitis, corneal affection, conjunctivitis, keratoconjunctivitis sicca, and cataract, in psoriatic patients compared to controls was observed. Importantly, significant associations between serum OPN levels and the presence of cataracts and intraocular pressure (IOP) were identified. Additionally, significant correlations between serum OPN levels and measures of visual acuity and ocular surface health were found.

Conclusions

Osteopontin is considered a marker of psoriasis severity and is associated with ocular comorbidities in psoriasis.

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
  • Department of Clinical Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
  • Department of Ophthalmology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.

Zitieren

APA

Elsadek, H. M., Kamel, R. O. M., Elsaid, M. A., Rashed, R. M., & Ali, M. S. (2024). Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?. Dermatology Practical & Conceptual, 14(4), e2024226. https://doi.org/10.5826/dpc.1404a226

Vancouver

Elsadek HM, Kamel ROM, Elsaid MA, Rashed RM, Ali MS. Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?. Dermatology Practical & Conceptual. 2024;14(4):e2024226. doi:10.5826/dpc.1404a226

BibTeX
@article{Elsadek2024,
  author = {Elsadek, Hala M and Kamel, Radwa O M and Elsaid, Marwa Abdallah and Rashed, Rasha Muhammad and Ali, Mona S},
  title = {Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?},
  journal = {Dermatology Practical & Conceptual},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {e2024226},
  doi = {10.5826/dpc.1404a226}
}
Kostenlos starten →